2016 No. 583
Prisons, England And Wales
Young Offender Institutions, England And Wales

The Prison and Young Offender Institution (Amendment) Rules 2016

Made
Laid before Parliament
Coming into force
The Secretary of State makes the following Rules in exercise of the powers conferred by sections 47(1) and (3A) of the Prison Act 19521.

Citation and commencement1.

These Rules may be cited as the Prison and Young Offender Institution (Amendment) Rules 2016 and come into force on 7th June 2016.

Amendment of the Prison Rules 19992.

(1)

The Prison Rules 19992 are amended as follows.

(2)

In rule 2(1) (interpretation)3, after the definition of “prison minister” insert—

““specified drug” means any product or substance containing—

(a)

AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide);

(b)

5F-AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-Fluoropentyl)-1H-indazole-3-carboxamide);

(c)

AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide);

(d)

APICA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide);

(e)

5F-APICA (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide);

(f)

APINACA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(g)

5F-APINACA (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(h)

5F-PB22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), and

(i)

MDMB-CHMICA (methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate);”.

(3)

In the heading to rule 50 (compulsory testing for controlled drugs), after “controlled drugs” insert “or specified drugs”.

(4)

In rule 50(1), after “controlled drug” insert “or specified drug”.

(5)

In rule 51 (offences against discipline)4, after “controlled drug”, in both places it occurs, insert “or specified drug”.

(6)

In rule 52 (defences to rule 51(9)), after “controlled drug”, wherever it appears, insert “or specified drug”.

Amendment of the Young Offender Institution Rules 20003.

(1)

The Young Offender Institution Rules 20005 are amended as follows.

(2)

In rule 2(1) (interpretation)6, after the definition of “officer” insert—

““specified drug” means any product or substance containing—

(a)

AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide);

(b)

5F-AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-Fluoropentyl)-1H-indazole-3-carboxamide);

(c)

AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide);

(d)

APICA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide);

(e)

5F-APICA (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide);

(f)

APINACA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(g)

5F-APINACA (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(h)

5F-PB22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), and

(i)

MDMB-CHMICA (methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate);”.

(3)

In the heading to rule 53 (compulsory testing for controlled drugs), after “controlled drugs” insert “or specified drugs”.

(4)

In rule 53(1), after “controlled drug” insert “or specified drug”.

(5)

In rule 55 (offences against discipline)7, after “controlled drug”, in both places it occurs, insert “or specified drug”.

(6)

In rule 56 (defences to rule 55(10)), after “controlled drug”, wherever it appears, insert “or specified drug”.

Andrew Selous
Parliamentary Under Secretary of State
Ministry of Justice
EXPLANATORY NOTE
(This note is not part of the Rules)

These Rules amend the Prison Rules 1999 (S.I. 1999/728) (“the 1999 Rules”) and the Young Offender Institution Rules 2000 (S.I. 2000/3371) (“the 2000 Rules”). These Rules specify substances or products which are “specified drugs” for the purposes of section 16A (testing prisoners for drugs) of the Prison Act 1952 (c. 52) (“the Act”). The effect of section 16A of the Act is that a prison officer can require a prisoner or an inmate to provide a sample for the purposes of ascertaining whether there is a specified drug in the body of the prisoner or inmate. The effect of the amendments to rules 2 and 50 (compulsory testing for controlled drugs) of the 1999 Rules and rules 2 and 53 (compulsory testing for controlled drugs) of the 2000 Rules is to list the specified drugs and provide for compulsory testing of those specified drugs.

The amendments to rule 51 (offences against discipline) of the 1999 Rules and rule 55 (offences against discipline) of the 2000 Rules create an offence against discipline where a prisoner or inmate is found with a specified drug in his or her body or receives a specified drug during the course of a visit without the consent of an officer. The amendments to rule 52 (defences to rule 51(9)) of the 1999 Rules and rule 56 (defences to rule 55(10)) of the 2000 Rules set out the defences to the offence against discipline.

A full impact assessment has not been produced for this instrument as no impact on the private, voluntary or public sectors is foreseen.